| Health Related Home Care | |
| 104 W Pickens Street, Abbeville, South Carolina 29620 | |
| (864) 366-9151 | |
| Name | Health Related Home Care |
|---|---|
| Location | 104 W Pickens Street, Abbeville, South Carolina |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 427076 |
| Ownership Type | Government - State/county |
| Service Area Zip Codes | 29006, 29037, 29108, 29127, 29129, 29138, 29145, 29166, 29178, 29325, 29332, 29335, 29351, 29360, 29369, 29370, 29384, 29388, 29484, 29607, 29620, 29621, 29624, 29625, 29626, 29627, 29628, 29630, 29638, 29639, 29643, 29644, 29645, 29646, 29649, 29653, 29654, 29655, 29666, 29680, 29684, 29689, 29692, 29697, 29819, 29821, 29824, 29832, 29835, 29838, 29839, 29840, 29844, 29845, 29847, 29848, 29860 |
| NPI Number | 1871694620 |
| Organization Name | ABBEVILLE COUNTY MEMORIAL HOSPITAL |
| Doing Business As | HEALTH RELATED HOME CARE |
| Address | 763 Highway 28 Byp Ste 17, Abbeville, SC 29620 |
| Phone Number | 864-366-9151 |
News Archive
LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2012.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the final analysis of the Phase 3 NExUS (NSCLC research Experience Utilizing Sorafenib) trial evaluating Nexavar® (sorafenib) tablets in patients with advanced non-squamous non-small cell lung cancer (NSCLC) showed that the study did not meet its primary endpoint of improving overall survival in the first-line setting.
A new drug is showing promise as a treatment for mesothelioma - one of the most lethal cancers of all.
News outlets offer updates regarding Medicaid expansion efforts in Indiana and Ohio.
It happens unexpectedly: a person long thought lost to the ravages of dementia, unable to recall the events of their lives or even recognize those closest to them, will suddenly wake up and exhibit surprisingly normal behavior, only to pass away shortly thereafter.
› Verified 6 days ago
| Quality Rating: |
News Archive
LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2012.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the final analysis of the Phase 3 NExUS (NSCLC research Experience Utilizing Sorafenib) trial evaluating Nexavar® (sorafenib) tablets in patients with advanced non-squamous non-small cell lung cancer (NSCLC) showed that the study did not meet its primary endpoint of improving overall survival in the first-line setting.
A new drug is showing promise as a treatment for mesothelioma - one of the most lethal cancers of all.
News outlets offer updates regarding Medicaid expansion efforts in Indiana and Ohio.
It happens unexpectedly: a person long thought lost to the ravages of dementia, unable to recall the events of their lives or even recognize those closest to them, will suddenly wake up and exhibit surprisingly normal behavior, only to pass away shortly thereafter.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.4 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 88.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 92.3 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.6 | 96.4 |
News Archive
LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2012.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the final analysis of the Phase 3 NExUS (NSCLC research Experience Utilizing Sorafenib) trial evaluating Nexavar® (sorafenib) tablets in patients with advanced non-squamous non-small cell lung cancer (NSCLC) showed that the study did not meet its primary endpoint of improving overall survival in the first-line setting.
A new drug is showing promise as a treatment for mesothelioma - one of the most lethal cancers of all.
News outlets offer updates regarding Medicaid expansion efforts in Indiana and Ohio.
It happens unexpectedly: a person long thought lost to the ravages of dementia, unable to recall the events of their lives or even recognize those closest to them, will suddenly wake up and exhibit surprisingly normal behavior, only to pass away shortly thereafter.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 84.2 | 79.6 |
| How often patients got better at getting in and out of bed | 89.1 | 81.1 |
| How often patients got better at bathing | 86.6 | 82.3 |
| How often patients’ breathing improved | 76.6 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 96.5 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 80.1 | 75 |
| How often home health patients had to be admitted to the hospital | 15.9 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.2 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99.7 | 94 |
News Archive
LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2012.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the final analysis of the Phase 3 NExUS (NSCLC research Experience Utilizing Sorafenib) trial evaluating Nexavar® (sorafenib) tablets in patients with advanced non-squamous non-small cell lung cancer (NSCLC) showed that the study did not meet its primary endpoint of improving overall survival in the first-line setting.
A new drug is showing promise as a treatment for mesothelioma - one of the most lethal cancers of all.
News outlets offer updates regarding Medicaid expansion efforts in Indiana and Ohio.
It happens unexpectedly: a person long thought lost to the ravages of dementia, unable to recall the events of their lives or even recognize those closest to them, will suddenly wake up and exhibit surprisingly normal behavior, only to pass away shortly thereafter.
› Verified 6 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2012.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the final analysis of the Phase 3 NExUS (NSCLC research Experience Utilizing Sorafenib) trial evaluating Nexavar® (sorafenib) tablets in patients with advanced non-squamous non-small cell lung cancer (NSCLC) showed that the study did not meet its primary endpoint of improving overall survival in the first-line setting.
A new drug is showing promise as a treatment for mesothelioma - one of the most lethal cancers of all.
News outlets offer updates regarding Medicaid expansion efforts in Indiana and Ohio.
It happens unexpectedly: a person long thought lost to the ravages of dementia, unable to recall the events of their lives or even recognize those closest to them, will suddenly wake up and exhibit surprisingly normal behavior, only to pass away shortly thereafter.
› Verified 6 days ago
The patient survey data of Health Related Home Care is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 92 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 90 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 87 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 93 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 89 | 78 |
News Archive
LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2012.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that the final analysis of the Phase 3 NExUS (NSCLC research Experience Utilizing Sorafenib) trial evaluating Nexavar® (sorafenib) tablets in patients with advanced non-squamous non-small cell lung cancer (NSCLC) showed that the study did not meet its primary endpoint of improving overall survival in the first-line setting.
A new drug is showing promise as a treatment for mesothelioma - one of the most lethal cancers of all.
News outlets offer updates regarding Medicaid expansion efforts in Indiana and Ohio.
It happens unexpectedly: a person long thought lost to the ravages of dementia, unable to recall the events of their lives or even recognize those closest to them, will suddenly wake up and exhibit surprisingly normal behavior, only to pass away shortly thereafter.
› Verified 6 days ago
Health Related Home Care Location: 104 W Pickens Street, Abbeville, South Carolina 29620 Ratings: Phone: (864) 366-9151 |